Dolomite and Mologic collaborate to scale-up manufacture of nanoparticles for COVID-19 diagnostic tests
2nd April 2020
Dolomite Microfluidics is pleased to announce a new collaboration with Mologic to combine ground-breaking diagnostic technology with continuous flow microfluidic manufacturing processes to accelerate the validation and wide-release of Mologic’s COVID-19 diagnostic test.
A COVID-19 update to all our customers and members of the scientific community
18th March 2020
A COVID-19 update to all our customers and members of the scientific community. We would like to reassure you that, at this challenging time, we are indeed fully operational and will provide the same level of support as usual. Furthermore, we are pleased to announce that we will extend our educational online content. Please read this article & stay tuned for more information on this!
Dolomite Microfluidics shares its expertise in core-shell microparticle production
5th March 2020
Read more about our latest application note, Microfluidic Production of 20 to 50 μm Core-Shell PLGA Beads, which is enabling scientists around the globe to benefit from the company’s in-depth knowledge of the encapsulation of hydrophilic materials, such as active pharmaceutical ingredients (APIs).
Dolomite Microfluidics highlights of MicroTAS 2019
14th November 2019
Another year of MicroTAS has passed us by, and we’d like to give you an update on our time spent at the 23rd International Conference on Miniaturized Systems for Chemistry and Life Sciences!
Taking a microfluidic approach to the production of taxane chemotherapeutics
15th October 2019
Researchers at the University of Porto in Porto, Portugal are using Dolomite Microfluidics chips to manufacture diverse therapeutic nanoplatforms, including an advanced microfluidic method for manufacture of taxane-loaded nanoparticles for cancer treatment.